244
Views
0
CrossRef citations to date
0
Altmetric
Review

5-Hydroxymethylcytosine: a Potential Therapeutic Target in Cancer

, &
Pages 503-514 | Published online: 28 Nov 2014

References

  • Smith ZD , MeissnerA . DNA methylation: roles in mammalian development . Nat. Rev. Genet.14 ( 3 ), 204 – 220 ( 2013 ).
  • Bestor T , LaudanoA , MattalianoR , IngramV . Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases . J. Mol. Biol.203 ( 4 ), 971 – 983 ( 1988 ).
  • Baylin S , BestorTH . Altered methylation patterns in cancer cell genomes: cause or consequence?Cancer Cell1 ( 4 ), 299 – 305 ( 2002 ).
  • Wu SC , ZhangY . Active DNA demethylation: many roads lead to Rome . Nat. Rev. Mol. Cell Biol.11 ( 9 ), 607 – 620 ( 2010 ).
  • Ooi SK , BestorTH . The colorful history of active DNA demethylation . Cell133 ( 7 ), 1145 – 1148 ( 2008 ).
  • Reik W , DeanW , WalterJ . Epigenetic reprogramming in mammalian development . Science293 ( 5532 ), 1089 – 1093 ( 2001 ).
  • Tahiliani M , KohKP , ShenYet al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 . Science324 ( 5929 ), 930 – 935 ( 2009 ).
  • Ito S , D’AlessioAC , TaranovaOV , HongK , SowersLC , ZhangY . Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification . Nature466 ( 7310 ), 1129 – 1133 ( 2010 ).
  • Yu M , HonGC , SzulwachKEet al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome . Cell149 ( 6 ), 1368 – 1380 ( 2012 ).
  • Haffner MC , ChauxA , MeekerAKet al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers . Oncotarget2 ( 8 ), 627 – 637 ( 2011 ).
  • Jin SG , KadamS , PfeiferGP . Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine . Nucleic Acids Res.38 ( 11 ), e125 ( 2010 ).
  • Sun Z , TerragniJ , BorgaroJGet al. High-resolution enzymatic mapping of genomic 5-hydroxymethylcytosine in mouse embryonic stem cells . Cell Rep.3 ( 2 ), 567 – 576 ( 2013 ).
  • Globisch D , MunzelM , MullerMet al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates . PLoS One5 ( 12 ), e15367 ( 2010 ).
  • Szwagierczak A , BultmannS , SchmidtCS , SpadaF , LeonhardtH . Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA . Nucleic Acids Res.38 ( 19 ), e181 ( 2010 ).
  • Ito S , ShenL , DaiQet al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine . Science333 ( 6047 ), 1300 – 1303 ( 2011 ).
  • Song CX , HeC . Potential functional roles of DNA demethylation intermediates . Trends Biochem. Sci.38 ( 10 ), 480 – 484 ( 2013 ).
  • Hashimoto H , ZhangX , ChengX . Excision of thymine and 5-hydroxymethyluracil by the MBD4 DNA glycosylase domain: structural basis and implications for active DNA demethylation . Nucleic Acids Res.40 ( 17 ), 8276 – 8284 ( 2012 ).
  • Cortellino S , XuJ , SannaiMet al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair . Cell146 ( 1 ), 67 – 79 ( 2011 ).
  • Kohli RM , ZhangY . TET enzymes, TDG and the dynamics of DNA demethylation . Nature502 ( 7472 ), 472 – 479 ( 2013 ).
  • Wu H , ZhangY . Reversing DNA methylation: mechanisms, genomics, and biological functions . Cell156 ( 1–2 ), 45 – 68 ( 2014 ).
  • Munzel M , GlobischD , CarellT . 5-Hydroxymethylcytosine, the sixth base of the genome . Angew. Chem. Int. Ed. Engl.50 ( 29 ), 6460 – 6468 ( 2011 ).
  • Yang H , LiuY , BaiFet al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation . Oncogene32 ( 5 ), 663 – 669 ( 2013 ).
  • Chen ML , ShenF , HuangWet al. Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry . Clin. Chem.59 ( 5 ), 824 – 832 ( 2013 ).
  • Jin SG , JiangY , QiuRet al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations . Cancer Res.71 ( 24 ), 7360 – 7365 ( 2011 ).
  • Orr BA , HaffnerMC , NelsonWG , YegnasubramanianS , EberhartCG . Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma . PLoS One7 ( 7 ), e41036 ( 2012 ).
  • Lian CG , XuY , CeolCet al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma . Cell150 ( 6 ), 1135 – 1146 ( 2012 ).
  • Ko M , HuangY , JankowskaAMet al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 . Nature468 ( 7325 ), 839 – 843 ( 2010 ).
  • Liu X , GuangsenZ , YiYet al. Decreased 5-hmC levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes . Leuk. Lymphoma54 ( 11 ), 2466 – 2473 ( 2013 ).
  • Liu X , ZhangG , YiYet al. Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes . Leuk. Lymphoma54 ( 11 ), 2466 – 2473 ( 2013 ).
  • Coppieters N , DieriksBV , LillC , FaullRL , CurtisMA , DragunowM . Global changes in DNA methylation and hydroxymethylation in Alzheimer’s disease human brain . Neurobiol. Aging35 ( 6 ), 1334 – 1344 ( 2014 ).
  • Chouliaras L , MastroeniD , DelvauxEet al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients . Neurobiol. Aging34 ( 9 ), 2091 – 2099 ( 2013 ).
  • Figueroa ME , Abdel-WahabO , LuCet al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation . Cancer Cell18 ( 6 ), 553 – 567 ( 2010 ).
  • Lorsbach RB , MooreJ , MathewS , RaimondiSC , MukatiraST , DowningJR . TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23) . Leukemia17 ( 3 ), 637 – 641 ( 2003 ).
  • Burmeister T , MeyerC , SchwartzSet al. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group . Blood113 ( 17 ), 4011 – 4015 ( 2009 ).
  • Huang H , JiangX , LiZet al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia . Proc. Natl Acad. Sci. USA110 ( 29 ), 11994 – 11999 ( 2013 ).
  • Kalender Atak Z , De KeersmaeckerK , GianfeliciVet al. High accuracy mutation detection in leukemia on a selected panel of cancer genes . PLoS One7 ( 6 ), e38463 ( 2012 ).
  • Hsu CH , PengKL , KangMLet al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases . Cell Rep.2 ( 3 ), 568 – 579 ( 2012 ).
  • Muller T , GessiM , WahaAet al. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas . Am. J. Pathol.181 ( 2 ), 675 – 683 ( 2012 ).
  • Delhommeau F , DupontS , Della ValleVet al. Mutation in TET2 in myeloid cancers . N. Engl. J. Med.360 ( 22 ), 2289 – 2301 ( 2009 ).
  • Langemeijer SM , KuiperRP , BerendsMet al. Acquired mutations in TET2 are common in myelodysplastic syndromes . Nat. Genet.41 ( 7 ), 838 – 842 ( 2009 ).
  • Abdel-Wahab O , MullallyA , HedvatCet al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies . Blood114 ( 1 ), 144 – 147 ( 2009 ).
  • Pronier E , AlmireC , MokraniHet al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors . Blood118 ( 9 ), 2551 – 2555 ( 2011 ).
  • Moran-Crusio K , ReavieL , ShihAet al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation . Cancer Cell20 ( 1 ), 11 – 24 ( 2011 ).
  • Quivoron C , CouronneL , Della ValleVet al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis . Cancer Cell20 ( 1 ), 25 – 38 ( 2011 ).
  • Freudenberg JM , GhoshS , LackfordBLet al. Acute depletion of Tet1-dependent 5-hydroxymethylcytosine levels impairs LIF/Stat3 signaling and results in loss of embryonic stem cell identity . Nucleic Acids Res.40 ( 8 ), 3364 – 3377 ( 2012 ).
  • Gu TP , GuoF , YangHet al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes . Nature477 ( 7366 ), 606 – 610 ( 2011 ).
  • Challen GA , SunD , JeongMet al. Dnmt3a is essential for hematopoietic stem cell differentiation . Nat. Genet.44 ( 1 ), 23 – 31 ( 2012 ).
  • Ley TJ , DingL , WalterMJet al. DNMT3A mutations in acute myeloid leukemia . N. Engl. J. Med.363 ( 25 ), 2424 – 2433 ( 2010 ).
  • Walter MJ , DingL , ShenDet al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes . Leukemia25 ( 7 ), 1153 – 1158 ( 2011 ).
  • Liutkeviciute Z , LukinaviciusG , MaseviciusV , DaujotyteD , KlimasauskasS . Cytosine-5-methyltransferases add aldehydes to DNA . Nat. Chem. Biol.5 ( 6 ), 400 – 402 ( 2009 ).
  • Chen CC , WangKY , ShenCK . The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases . J. Biol. Chem.287 ( 40 ), 33116 – 33121 ( 2012 ).
  • Jeong M , SunD , LuoMet al. Large conserved domains of low DNA methylation maintained by Dnmt3a . Nat. Genet.46 ( 1 ), 17 – 23 ( 2014 ).
  • Fuks F , HurdPJ , DeplusR , KouzaridesT . The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase . Nucleic Acids Res.31 ( 9 ), 2305 – 2312 ( 2003 ).
  • D’Alessio AC , WeaverIC , SzyfM . Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes . Mol. Cell. Biol.27 ( 21 ), 7462 – 7474 ( 2007 ).
  • Turcan S , RohleD , GoenkaAet al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype . Nature483 ( 7390 ), 479 – 483 ( 2012 ).
  • Patnaik MM , HansonCA , HodnefieldJMet al. Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients . Leukemia26 ( 1 ), 101 – 105 ( 2012 ).
  • Koivunen P , LeeS , DuncanCGet al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation . Nature483 ( 7390 ), 484 – 488 ( 2012 ).
  • Losman JA , LooperRE , KoivunenPet al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible . Science339 ( 6127 ), 1621 – 1625 ( 2013 ).
  • Xiao M , YangH , XuWet al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors . Genes Dev.26 ( 12 ), 1326 – 1338 ( 2012 ).
  • Mason EF , HornickJL . Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis . Mod. Pathol.26 ( 11 ), 1492 – 1497 ( 2013 ).
  • Castro-Vega LJ , BuffetA , De CubasAAet al. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas . Hum. Mol. Genet.23 ( 9 ), 2440 – 2446 ( 2014 ).
  • Mellen M , AyataP , DewellS , KriaucionisS , HeintzN . MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system . Cell151 ( 7 ), 1417 – 1430 ( 2012 ).
  • Szulwach KE , LiX , LiYet al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging . Nat. Neurosci.14 ( 12 ), 1607 – 1616 ( 2011 ).
  • Ng HH , ZhangY , HendrichBet al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex . Nat. Genet.23 ( 1 ), 58 – 61 ( 1999 ).
  • Ng HH , JeppesenP , BirdA . Active repression of methylated genes by the chromosomal protein MBD1 . Mol. Cell. Biol.20 ( 4 ), 1394 – 1406 ( 2000 ).
  • Yildirim O , LiR , HungJHet al. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells . Cell147 ( 7 ), 1498 – 1510 ( 2011 ).
  • Xu J , ZhuW , XuWet al. Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair . Int. J. Oncol.42 ( 6 ), 2046 – 2052 ( 2013 ).
  • Mian OY , WangSZ , ZhuSZet al. Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells . Mol. Cancer Res.9 ( 8 ), 1152 – 1162 ( 2011 ).
  • Zhao S , ChoiM , OvertonJDet al. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma . Proc. Natl Acad. Sci. USA110 ( 8 ), 2916 – 2921 ( 2013 ).
  • Hendrich B , HardelandU , NgHH , JiricnyJ , BirdA . The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites . Nature401 ( 6750 ), 301 – 304 ( 1999 ).
  • Rai K , HugginsIJ , JamesSR , KarpfAR , JonesDA , CairnsBR . DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45 . Cell135 ( 7 ), 1201 – 1212 ( 2008 ).
  • Millar CB , GuyJ , SansomOJet al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice . Science297 ( 5580 ), 403 – 405 ( 2002 ).
  • Riccio A , AaltonenLA , GodwinAKet al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability . Nat. Genet.23 ( 3 ), 266 – 268 ( 1999 ).
  • Hardeland U , BenteleM , JiricnyJ , ScharP . The versatile thymine DNA-glycosylase: a comparative characterization of the human, Drosophila and fission yeast orthologs . Nucleic Acids Res.31 ( 9 ), 2261 – 2271 ( 2003 ).
  • He YF , LiBZ , LiZet al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA . Science333 ( 6047 ), 1303 – 1307 ( 2011 ).
  • Li YQ , ZhouPZ , ZhengXD , WalshCP , XuGL . Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair . Nucleic Acids Res.35 ( 2 ), 390 – 400 ( 2007 ).
  • Broderick P , BagratuniT , VijayakrishnanJ , LubbeS , ChandlerI , HoulstonRS . Evaluation of NTHL1, NEIL1, NEIL2, MPG, TDG, UNG and SMUG1 genes in familial colorectal cancer predisposition . BMC Cancer6 , 243 ( 2006 ).
  • Vasovcak P , KrepelovaA , MenigattiMet al. Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency . DNA Repair (Amsterdam)11 ( 7 ), 616 – 623 ( 2012 ).
  • Cortazar D , KunzC , SelfridgeJet al. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability . Nature470 ( 7334 ), 419 – 423 ( 2011 ).
  • Song CX , SzulwachKE , FuYet al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine . Nat. Biotechnol.29 ( 1 ), 68 – 72 ( 2011 ).
  • Booth MJ , BrancoMR , FiczGet al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution . Science336 ( 6083 ), 934 – 937 ( 2012 ).
  • Song CX , SzulwachKE , DaiQet al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming . Cell153 ( 3 ), 678 – 691 ( 2013 ).
  • Lu X , SongCX , SzulwachKet al. Chemical modification-assisted bisulfite sequencing (CAB-Seq) for 5-carboxylcytosine detection in DNA . J. Am. Chem. Soc.135 ( 25 ), 9315 – 9317 ( 2013 ).
  • Wen L , LiX , YanLet al. Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain . Genome Biol.15 ( 3 ), R49 ( 2014 ).
  • Thomson JP , HunterJM , LempiainenHet al. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver . Nucleic Acids Res.41 ( 11 ), 5639 – 5654 ( 2013 ).
  • Gao F , XiaY , WangJet al. Integrated detection of both 5-mC and 5-hmC by high-throughput tag sequencing technology highlights methylation reprogramming of bivalent genes during cellular differentiation . Epigenetics8 ( 4 ), 421 – 430 ( 2013 ).
  • Bhattacharyya S , YuY , SuzukiMet al. Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer . Nucleic Acids Res.41 ( 16 ), e157 ( 2013 ).
  • Fenaux P , MuftiGJ , Hellstrom-LindbergEet al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study . Lancet Oncol.10 ( 3 ), 223 – 232 ( 2009 ).
  • Fenaux P , MuftiGJ , Hellstrom-LindbergEet al. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia . J. Clin. Oncol.28 ( 4 ), 562 – 569 ( 2010 ).
  • Piekarz RL , FryeR , TurnerMet al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma . J. Clin. Oncol.27 ( 32 ), 5410 – 5417 ( 2009 ).
  • Dawson MA , KouzaridesT . Cancer epigenetics: from mechanism to therapy . Cell150 ( 1 ), 12 – 27 ( 2012 ).
  • Gadalla KK , BaileyME , CobbSR . MeCP2 and Rett syndrome: reversibility and potential avenues for therapy . Biochem. J.439 ( 1 ), 1 – 14 ( 2011 ).
  • Gregory DJ , MikhaylovaL , FedulovAV . Selective DNA demethylation by fusion of TDG with a sequence-specific DNA-binding domain . Epigenetics7 ( 4 ), 344 – 349 ( 2012 ).
  • Maeder ML , AngstmanJF , RichardsonMEet al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins . Nat. Biotechnol.31 ( 12 ), 1137 – 1142 ( 2013 ).
  • van der Oost J . Molecular biology. New tool for genome surgery . Science339 ( 6121 ), 768 – 770 ( 2013 ).
  • Rohle D , Popovici-mullerJ , PalaskasNet al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells . Science340 ( 6132 ), 626 – 630 ( 2013 ).
  • Wang F , TravinsJ , DeLaBarreBet al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation . Science340 ( 6132 ), 622 – 626 ( 2013 ).
  • Cunha S , LinYC , GoossenEAet al. The RON receptor tyrosine kinase promotes metastasis by triggering MBD4-dependent DNA methylation reprogramming . Cell Rep.6 ( 1 ), 141 – 154 ( 2014 ).
  • Slack A , BovenziV , BigeyPet al. Antisense MBD2 gene therapy inhibits tumorigenesis . J. Gene Med.4 ( 4 ), 381 – 389 ( 2002 ).
  • Rais Y , ZviranA , GeulaSet al. Deterministic direct reprogramming of somatic cells to pluripotency . Nature502 ( 7469 ), 65 – 70 ( 2013 ).
  • Pennarossa G , MaffeiS , CampagnolM , TarantiniL , GandolfiF , BreviniTA . Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells . Proc. Natl Acad. Sci. USA110 ( 22 ), 8948 – 8953 ( 2013 ).
  • Juergens RA , WrangleJ , VendettiFPet al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer . Cancer Discov.1 ( 7 ), 598 – 607 ( 2011 ).
  • Fu S , HuW , IyerRet al. Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer . Cancer117 ( 8 ), 1661 – 1669 ( 2011 ).
  • Fu X , JinL , WangXet al. MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation . Proc. Natl Acad. Sci. USA110 ( 44 ), 17892 – 17897 ( 2013 ).
  • Song SJ , ItoK , AlaUet al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation . Cell Stem Cell13 ( 1 ), 87 – 101 ( 2013 ).
  • Song SJ , PolisenoL , SongMSet al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling . Cell154 ( 2 ), 311 – 324 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.